Published in J Mol Biol on February 02, 2010
Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly. Nucleic Acids Res (2011) 1.06
Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Nucleic Acids Res (2012) 0.83
Structural basis for the oligomerization of the MADS domain transcription factor SEPALLATA3 in Arabidopsis. Plant Cell (2014) 0.83
Association of MEF2A gene polymorphisms with coronary artery disease. Iran Red Crescent Med J (2014) 0.80
Molecular cloning and in silico analysis of the duck (Anas platyrhynchos) MEF2A gene cDNA and its expression profile in muscle tissues during fetal development. Genet Mol Biol (2012) 0.78
Crystallization studies of the keratin-like domain from Arabidopsis thaliana SEPALLATA 3. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.77
DNA Shape versus Sequence Variations in the Protein Binding Process. Biophys J (2016) 0.76
Protein interaction evolution from promiscuity to specificity with reduced flexibility in an increasingly complex network. Sci Rep (2017) 0.75
Myocyte Enhancer Factor-2A Gene Mutation and Coronary Artery Disease. Chin Med J (Engl) (2015) 0.75
Molecular modeling and expression analysis of a MADS-box cDNA from mango (Mangifera indica L.). 3 Biotech (2013) 0.75
Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface. JCI Insight (2017) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90
ZDOCK: an initial-stage protein-docking algorithm. Proteins (2003) 7.52
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell (2002) 7.10
Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med (2007) 6.61
HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J (1999) 5.54
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol (1989) 4.72
MEF2: a central regulator of diverse developmental programs. Development (2007) 4.70
Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science (2006) 4.68
The MADS-box family of transcription factors. Eur J Biochem (1995) 4.54
BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J (1997) 4.51
DNA binding site sequence directs glucocorticoid receptor structure and activity. Science (2009) 4.48
A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science (2006) 4.42
An initial blueprint for myogenic differentiation. Genes Dev (2005) 4.22
The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev (2006) 4.18
New genes involved in cancer identified by retroviral tagging. Nat Genet (2002) 4.14
Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev (1992) 4.10
Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron (2008) 3.65
Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science (1995) 3.64
Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol (1997) 3.62
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J (2000) 3.59
Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science (2003) 3.34
A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development. Dev Cell (2006) 3.29
Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24
Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science (1999) 3.19
Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev (2001) 3.17
Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev (1995) 3.16
Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron (2008) 3.01
MEF-2 function is modified by a novel co-repressor, MITR. EMBO J (1999) 2.71
Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet (2002) 2.53
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest (2008) 2.24
Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J (2000) 2.22
Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science (1999) 2.17
Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science (2009) 2.13
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol (2006) 2.01
Class II histone deacetylases: structure, function, and regulation. Biochem Cell Biol (2001) 2.00
A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev Biol (1995) 1.98
The Saccharomyces cerevisiae MADS-box transcription factor Rlm1 is a target for the Mpk1 mitogen-activated protein kinase pathway. Mol Cell Biol (1997) 1.89
Quantitative discrimination of MEF2 sites. Mol Cell Biol (1996) 1.84
Strategies for macromolecular synchrotron crystallography. Structure (2000) 1.75
Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity (2000) 1.64
Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J Biol Chem (2000) 1.61
The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev (2000) 1.59
Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol Cell (2006) 1.54
Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J Mol Biol (2005) 1.38
Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J Biol Chem (1995) 1.35
Crystal structure of MEF2A core bound to DNA at 1.5 A resolution. J Mol Biol (2000) 1.33
Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. Nature (2003) 1.32
Solution structure of the MEF2A-DNA complex: structural basis for the modulation of DNA bending and specificity by MADS-box transcription factors. EMBO J (2000) 1.15
Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation (2008) 1.13
Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci (2004) 1.08
Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia. Leukemia (2005) 1.06
Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res (2001) 1.04
p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor. Biochem J (2003) 0.83
A molecular mechanism of temperature sensitivity for mutations affecting the Drosophila muscle regulator Myocyte enhancer factor-2. Genetics (2009) 0.83
Mapping and sequencing of structural variation from eight human genomes. Nature (2008) 30.28
Genome-wide atlas of gene expression in the adult mouse brain. Nature (2006) 28.02
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science (2007) 10.60
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell (2006) 10.19
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev (2003) 9.39
FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell (2006) 9.24
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev (2005) 8.95
The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science (2009) 8.23
The genome of a songbird. Nature (2010) 5.90
Genome analysis of the platypus reveals unique signatures of evolution. Nature (2008) 5.74
Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med (2013) 5.38
Genome architectures revealed by tethered chromosome conformation capture and population-based modeling. Nat Biotechnol (2011) 4.56
DNA binding site sequence directs glucocorticoid receptor structure and activity. Science (2009) 4.48
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution. Nat Neurosci (2007) 4.28
Comparative and demographic analysis of orang-utan genomes. Nature (2011) 3.83
A burst of segmental duplications in the genome of the African great ape ancestor. Nature (2009) 3.63
Evolutionary toggling of the MAPT 17q21.31 inversion region. Nat Genet (2008) 3.42
Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle (2009) 3.14
A distal enhancer in the interferon-gamma (IFN-gamma) locus revealed by genome sequence comparison. J Biol Chem (2003) 2.59
Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol Cell (2004) 2.55
Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med (2003) 2.50
Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology (2012) 2.47
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis. Tumour Biol (2014) 2.19
Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int J Parasitol (2008) 2.19
Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood (2007) 2.18
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem (2004) 2.12
Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am J Trop Med Hyg (2005) 2.02
Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc Natl Acad Sci U S A (2005) 2.00
Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A (2004) 1.97
Physical tethering and volume exclusion determine higher-order genome organization in budding yeast. Genome Res (2012) 1.95
Importance of multi-modal approaches to effectively identify cataract cases from electronic health records. J Am Med Inform Assoc (2012) 1.79
Broadband cavity ringdown spectroscopy for sensitive and rapid molecular detection. Science (2006) 1.74
Behavioral oscillations in attention: rhythmic α pulses mediated through θ band. J Neurosci (2014) 1.69
Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol (2007) 1.67
Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology (2010) 1.66
Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1. Proc Natl Acad Sci U S A (2009) 1.66
Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice. Arthritis Rheum (2012) 1.66
US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. Radiology (2012) 1.66
microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun (2010) 1.63
Structure of the forkhead domain of FOXP2 bound to DNA. Structure (2006) 1.61
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. Emerg Infect Dis (2009) 1.61
Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol (2003) 1.60
Ligand-binding domain of an α7-nicotinic receptor chimera and its complex with agonist. Nat Neurosci (2011) 1.58
Effect of transplantation with autologous bone marrow stem cells on acute myocardial infarction. Int J Cardiol (2011) 1.57
The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies. Nucl Med Commun (2004) 1.54
Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res (2005) 1.51
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol Cell Biol (2007) 1.50
Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis. Blood (2013) 1.49
An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell (2013) 1.49
microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis (2011) 1.48
Gorilla genome structural variation reveals evolutionary parallelisms with chimpanzee. Genome Res (2011) 1.47
Mutation spectrum of and founder effects affecting the PTS gene in East Asian populations. J Hum Genet (2012) 1.46
Structure of a TonEBP-DNA complex reveals DNA encircled by a transcription factor. Nat Struct Biol (2002) 1.45
A genetic algorithm for predicting the structures of interfaces in multicomponent systems. Nat Mater (2010) 1.44
Diagnostic accuracy of 320-slice computed tomography angiography for detection of coronary artery stenosis: meta-analysis. Int J Cardiol (2013) 1.44
Activated mesenchymal stem cells increase wound tensile strength in aged mouse model via macrophages. J Surg Res (2012) 1.44
Kinase peptide specificity: improved determination and relevance to protein phosphorylation. Proc Natl Acad Sci U S A (2004) 1.43
Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development (2003) 1.43
Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. Structure (2010) 1.39
Occlusion of the abdominal aorta in a patient with chronic atrial fibrillation. Eur J Cardiothorac Surg (2011) 1.39
Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J Mol Biol (2005) 1.38
Observation of dipolar spin-exchange interactions with lattice-confined polar molecules. Nature (2013) 1.37
Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element. Nat Struct Biol (2003) 1.37
Analysis of recent segmental duplications in the bovine genome. BMC Genomics (2009) 1.36
Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs. Antimicrob Agents Chemother (2008) 1.36
Noninvasive in vivo tomographic optical imaging of cellular morphology in the breast: possible convergence of microscopic pathology and macroscopic radiology. Med Phys (2008) 1.35
Mechanistic insights revealed by the crystal structure of a histidine kinase with signal transducer and sensor domains. PLoS Biol (2013) 1.35
Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J Allergy Clin Immunol (2011) 1.35
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res (2009) 1.35
HIV prevalence and related risk factors among male sex workers in Shenzhen, China: results from a time-location sampling survey. Sex Transm Infect (2009) 1.34
A map of WW domain family interactions. Proteomics (2004) 1.34
Sr lattice clock at 1 x 10(-16) fractional uncertainty by remote optical evaluation with a Ca clock. Science (2008) 1.34
Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. Ann Acad Med Singapore (2008) 1.33
Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. Nature (2003) 1.32
Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res (2006) 1.31
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model. Cancer Immunol Immunother (2009) 1.30
Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS One (2011) 1.30
Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect Immun (2009) 1.29
The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. Prostate (2004) 1.29
Psychosocial factors in association with condom use during commercial sex among migrant male sex workers living in Shenzhen, mainland China who serve cross-border Hong Kong male clients. AIDS Behav (2009) 1.27
Preparation, facile deprotonation, and rapid H/D exchange of the mu-hydride diiron model complexes of the [FeFe]-hydrogenase containing a pendant amine in a chelating diphosphine ligand. Inorg Chem (2009) 1.27
Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol (2010) 1.25
Convergent evolution of a new arsenic binding site in the ArsR/SmtB family of metalloregulators. J Biol Chem (2007) 1.25
Crystal structure of a conserved N-terminal domain of histone deacetylase 4 reveals functional insights into glutamine-rich domains. Proc Natl Acad Sci U S A (2007) 1.24
Structural, biochemical, and functional analyses of CED-9 recognition by the proapoptotic proteins EGL-1 and CED-4. Mol Cell (2004) 1.23
The G protein G alpha(13) is required for growth factor-induced cell migration. Dev Cell (2006) 1.23
Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity (2011) 1.23
Poly[diaquabis(μ-4,4'-bipyridine-κ2N:N')bis(ethane-1,2-diol)di-μ-sulfato-dicopper(II)]. Acta Crystallogr C (2011) 1.22
The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One (2013) 1.22
Synthesis and structure of silver complexes with nicotinate-type ligands having antibacterial activities against clinically isolated antibiotic resistant pathogens. Inorg Chem (2007) 1.21